SG11202000444PA - Sequencing output determination and analysis with target-associated molecules in quantification associated with biological targets - Google Patents

Sequencing output determination and analysis with target-associated molecules in quantification associated with biological targets

Info

Publication number
SG11202000444PA
SG11202000444PA SG11202000444PA SG11202000444PA SG11202000444PA SG 11202000444P A SG11202000444P A SG 11202000444PA SG 11202000444P A SG11202000444P A SG 11202000444PA SG 11202000444P A SG11202000444P A SG 11202000444PA SG 11202000444P A SG11202000444P A SG 11202000444PA
Authority
SG
Singapore
Prior art keywords
target
spike
international
associated molecules
molecules
Prior art date
Application number
SG11202000444PA
Other languages
English (en)
Inventor
David Tsao
Oguzhan Atay
Original Assignee
Billiontoone Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Billiontoone Inc filed Critical Billiontoone Inc
Publication of SG11202000444PA publication Critical patent/SG11202000444PA/en

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/101—Sanger sequencing method, i.e. oligonucleotide sequencing using primer elongation and dideoxynucleotides as chain terminators
SG11202000444PA 2017-08-04 2018-08-06 Sequencing output determination and analysis with target-associated molecules in quantification associated with biological targets SG11202000444PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762541565P 2017-08-04 2017-08-04
PCT/US2018/045419 WO2019028470A2 (fr) 2017-08-04 2018-08-06 Détermination et analyse des sorties de séquençage à l'aide de molécules associées à une cible dans une quantification associée à des cibles biologiques

Publications (1)

Publication Number Publication Date
SG11202000444PA true SG11202000444PA (en) 2020-02-27

Family

ID=65234231

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202000444PA SG11202000444PA (en) 2017-08-04 2018-08-06 Sequencing output determination and analysis with target-associated molecules in quantification associated with biological targets

Country Status (12)

Country Link
US (2) US11430543B2 (fr)
EP (1) EP3662085B1 (fr)
JP (2) JP6955732B2 (fr)
KR (1) KR102372572B1 (fr)
CN (1) CN111094583A (fr)
AU (1) AU2018312117B2 (fr)
BR (1) BR112020002260A2 (fr)
CA (2) CA3071366C (fr)
ES (1) ES2923478T3 (fr)
IL (1) IL272399A (fr)
SG (1) SG11202000444PA (fr)
WO (1) WO2019028470A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019028462A1 (fr) 2017-08-04 2019-02-07 Billiontoone, Inc. Molécules associées à une cible pour une caractérisation associée à des cibles biologiques
US11519024B2 (en) 2017-08-04 2022-12-06 Billiontoone, Inc. Homologous genomic regions for characterization associated with biological targets
EP3931356A1 (fr) * 2019-02-28 2022-01-05 Inivata Ltd. Procédé de quantification de la quantité d'une séquence cible dans un échantillon d'acide nucléique
US20210057038A1 (en) * 2019-07-25 2021-02-25 Prime Discoveries, Inc. Systems and methods for microbiome based sample classification
JP2023510424A (ja) * 2020-01-17 2023-03-13 深▲せん▼華大智造科技有限公司 Ｄｎａのセンス鎖とアンチセンス鎖のシーケンシングを同期させる方法
US11769332B2 (en) * 2020-06-15 2023-09-26 Lytx, Inc. Sensor fusion for collision detection
WO2022204322A1 (fr) * 2021-03-23 2022-09-29 Billiontoone, Inc. Analyse de fragments pour le diagnostic quantitatif de cibles biologiques

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7655443B1 (en) * 1999-05-07 2010-02-02 Siemens Healthcare Diagnostics, Inc. Nucleic acid sequencing with simultaneous quantitation
US7709194B2 (en) 2004-06-04 2010-05-04 The Chinese University Of Hong Kong Marker for prenatal diagnosis and monitoring
KR100808312B1 (ko) * 2004-07-26 2008-02-27 홍경만 인위적 에스엔피 서열의 동시증폭을 이용한 염색체,유전자, 혹은 특정 뉴클레오티드 서열의 카피 수 측정방법
US20070009884A1 (en) 2005-04-11 2007-01-11 Ghc Technologies, Inc. Methods and apparatuses for detecting chemical or biological agents
GB2425337A (en) 2005-04-22 2006-10-25 Uponor Innovation Ab Electrofusion fitting to seal barrier layer of composite pipe
US10081839B2 (en) 2005-07-29 2018-09-25 Natera, Inc System and method for cleaning noisy genetic data and determining chromosome copy number
US20070092869A1 (en) 2005-10-24 2007-04-26 Fulmer-Smentek Stephanie B Spike-in controls and methods for using the same
US8105422B2 (en) 2006-06-29 2012-01-31 Shell Oil Company Cyclonic liquid degassing separator and method for degassing a fluid mixture
US20080124712A1 (en) 2006-10-26 2008-05-29 Hantash Feras M Alpha globin gene dosage assay
EP2334812B1 (fr) 2008-09-20 2016-12-21 The Board of Trustees of The Leland Stanford Junior University Diagnostic non invasif d'aneuploïdie foetale par sequençage
TWI350312B (en) 2009-03-16 2011-10-11 Univ Kaohsiung Medical Method for determining smn gene transfer and intragenic mutations
PT3783110T (pt) 2009-11-05 2023-01-02 Sequenom Inc Análise genómica fetal a partir de uma amostra biológica materna
ES2577017T3 (es) 2009-12-22 2016-07-12 Sequenom, Inc. Procedimientos y kits para identificar la aneuploidia
CN102782158A (zh) 2010-01-15 2012-11-14 不列颠哥伦比亚大学 用于检测核酸变异的多重扩增
US20120270739A1 (en) 2010-01-19 2012-10-25 Verinata Health, Inc. Method for sample analysis of aneuploidies in maternal samples
AU2011207544A1 (en) 2010-01-19 2012-09-06 Verinata Health, Inc. Identification of polymorphic sequences in mixtures of genomic DNA by whole genome sequencing
WO2011090556A1 (fr) * 2010-01-19 2011-07-28 Verinata Health, Inc. Procédés pour déterminer une fraction d'acide nucléique fœtal dans des échantillons maternels
ES2534758T3 (es) 2010-01-19 2015-04-28 Verinata Health, Inc. Métodos de secuenciación en diagnósticos prenatales
WO2011156795A2 (fr) 2010-06-11 2011-12-15 Pathogenica, Inc. Acides nucléiques pour la détection multiplex d'organismes et leurs procédés d'utilisation et de production
CA2802111A1 (fr) 2010-07-23 2012-01-26 Esoterix Genetic Laboratories, Llc Identification de regions genomiques foetales ou maternelles differentiellement representees et ses utilisations
BR112013001754A2 (pt) * 2010-07-23 2016-05-31 Harvard College método para detectar marcas de doença ou condições em fluídos corpóreos
CN103534591B (zh) 2010-10-26 2016-04-06 利兰·斯坦福青年大学托管委员会 通过测序分析进行的非侵入性胎儿遗传筛选
US8877442B2 (en) 2010-12-07 2014-11-04 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive determination of fetal inheritance of parental haplotypes at the genome-wide scale
US9260753B2 (en) 2011-03-24 2016-02-16 President And Fellows Of Harvard College Single cell nucleic acid detection and analysis
US8688388B2 (en) 2011-10-11 2014-04-01 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
AU2013229762A1 (en) 2012-03-09 2014-09-25 Caris Life Sciences Switzerland Holdings Gmbh Biomarker compositions and methods
EP2834376B1 (fr) * 2012-04-06 2017-03-15 The Chinese University Of Hong Kong Diagnostic prénatal non invasif de trisomie foetale par analyse du taux d'allèles au moyen d'un séquençage massif parallèle ciblé
US20150284783A1 (en) 2012-05-21 2015-10-08 Agena Bioscience, Inc. Methods and compositions for analyzing nucleic acid
EP2893040B1 (fr) 2012-09-04 2019-01-02 Guardant Health, Inc. Procédés pour détecter des mutations rares et une variation de nombre de copies
US20160040229A1 (en) 2013-08-16 2016-02-11 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
JP6009096B2 (ja) 2012-11-26 2016-10-19 ザ・ユニバーシティ・オブ・トレド 核酸の標準化された配列決定のための方法およびその使用
US9944973B2 (en) 2012-11-26 2018-04-17 The University Of Toledo Methods for standardized sequencing of nucleic acids and uses thereof
US10643738B2 (en) * 2013-01-10 2020-05-05 The Chinese University Of Hong Kong Noninvasive prenatal molecular karyotyping from maternal plasma
WO2014127484A1 (fr) 2013-02-21 2014-08-28 British Columbia Cancer Agency Branch Acides nucléiques de contrôle externe pour le traçage d'échantillons
CA2909861C (fr) * 2013-04-25 2022-12-06 Firefly Bioworks, Inc. Analyse multiplexee d'acides nucleiques cibles
JP5789720B2 (ja) 2013-07-31 2015-10-07 株式会社日立製作所 遺伝子変異分析装置、遺伝子変異分析システム及び遺伝子変異分析方法
EP3052632A4 (fr) 2013-10-04 2017-03-29 Rana Therapeutics, Inc. Compositions et méthodes pour traiter la sclérose latérale amyotrophique (sla)
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US11339435B2 (en) 2013-10-18 2022-05-24 Molecular Loop Biosciences, Inc. Methods for copy number determination
KR102205950B1 (ko) 2013-11-07 2021-01-22 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 인간 마이크로바이옴 및 그의 성분의 분석을 위한 무세포 핵산
US10570443B2 (en) 2014-10-01 2020-02-25 Chronix Biomedical Methods of quantifying cell-free DNA
WO2016094947A1 (fr) * 2014-12-16 2016-06-23 Garvan Institute Of Medical Research Témoins de séquençage
FR3031369B1 (fr) 2015-01-07 2017-10-20 Valeo Embrayages Dispositif d'amortissement d'oscillations de torsion
US10844428B2 (en) 2015-04-28 2020-11-24 Illumina, Inc. Error suppression in sequenced DNA fragments using redundant reads with unique molecular indices (UMIS)
EP3304093B1 (fr) * 2015-05-28 2023-12-27 Immunexpress Pty Ltd Validation de mesure de biomarqueurs
CA3185611A1 (fr) 2016-03-25 2017-09-28 Karius, Inc. Spike-ins d'acides nucleiques synthetiques
US11208679B2 (en) 2016-05-31 2021-12-28 The Translational Genomics Research Institute Method for validating assays of biological samples
WO2018031486A1 (fr) 2016-08-08 2018-02-15 Karius, Inc. Réduction du signal provenant d'acides nucléiques contaminants
US11519024B2 (en) * 2017-08-04 2022-12-06 Billiontoone, Inc. Homologous genomic regions for characterization associated with biological targets
WO2019028462A1 (fr) * 2017-08-04 2019-02-07 Billiontoone, Inc. Molécules associées à une cible pour une caractérisation associée à des cibles biologiques
US20210292829A1 (en) * 2020-03-23 2021-09-23 Billiontoone, Inc. High throughput assays for detecting infectious diseases using capillary electrophoresis

Also Published As

Publication number Publication date
ES2923478T3 (es) 2022-09-27
AU2018312117A1 (en) 2020-02-06
US11430543B2 (en) 2022-08-30
JP6955732B2 (ja) 2021-10-27
EP3662085A2 (fr) 2020-06-10
JP7387110B2 (ja) 2023-11-28
KR20200098475A (ko) 2020-08-20
CA3071366C (fr) 2023-08-01
WO2019028470A3 (fr) 2019-06-06
CA3071366A1 (fr) 2019-02-07
EP3662085B1 (fr) 2022-06-22
US20230197202A1 (en) 2023-06-22
AU2018312117B2 (en) 2022-05-12
EP3662085A4 (fr) 2021-05-05
JP2020529202A (ja) 2020-10-08
WO2019028470A2 (fr) 2019-02-07
US20190095577A1 (en) 2019-03-28
JP2022008482A (ja) 2022-01-13
BR112020002260A2 (pt) 2020-09-08
IL272399A (en) 2020-03-31
CA3202766A1 (fr) 2019-02-07
CN111094583A (zh) 2020-05-01
KR102372572B1 (ko) 2022-03-08

Similar Documents

Publication Publication Date Title
SG11202000444PA (en) Sequencing output determination and analysis with target-associated molecules in quantification associated with biological targets
SG11201909154SA (en) Bispecific antibodies specifically binding to pd1 and lag3
SG11201806190TA (en) Isotachophoresis for purification of nucleic acids
SG11201909205YA (en) Immunoconjugates of an anti-pd-1 antibody with a mutant il-2 or with il-15
SG11201809913PA (en) Methods for detecting target nucleic acids in a sample
SG11201903519UA (en) Methods and systems for barcoding nucleic acid molecules from individual cells or cell populations
SG11201908489XA (en) De novo synthesized combinatorial nucleic acid libraries
SG11201908719QA (en) Biomarkers and car t cell therapies with enhanced efficacy
SG11201804506RA (en) Systems and methods for rendering multiple levels of detail
SG11201908549RA (en) Automated quality control and spectral error correction for sample analysis instruments
SG11201901371XA (en) Methods for the detection of genomic copy changes in dna samples
SG11201907764PA (en) Methods for screening infections
SG11201810611YA (en) Coumarin compounds and their uses as fluorescent labels
SG11201805906WA (en) Diagnostic and prognostic methods for cardiovascular diseases and events
SG11201908767QA (en) Method for accurate diagnosis of a disease targeting biomarkers in liquid biopsy
SG11201908509TA (en) Biosensors for biological or chemical analysis and methods of manufacturing the same
SG11201901730QA (en) Method and system for crispr-based library preparation and sequencing
SG11201906717SA (en) Methods and systems for associating physical and genetic properties of biological particles
SG11201909916YA (en) Compositions and methods for improving sample identification in indexed nucleic acid libraries
SG11201811315PA (en) Reagent channel mixing system and method
SG11201907607VA (en) Use of biomarkers in identifying cancer patients that will be responsive to treatment with a prmt5 inhibitor
SG11201809252YA (en) Methods for determining dpp3 and therapeutic methods
SG11201806432PA (en) Methods for assessing risk of developing colorectal cancer
SG11201910195WA (en) Methods for trapping and barcoding discrete biological units in hydrogel
SG11201907208XA (en) Radiolabeled anti-lag3 antibodies for immuno-pet imaging